Jason Throne - 27 Jun 2024 Form 4 Insider Report for IDEAYA Biosciences, Inc. (IDYA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
27 Jun 2024, 18:47:10 UTC
Prior SEC filing
04 Mar 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jason Throne

Key filing fact

Jason Throne filed Form 4 for IDEAYA Biosciences, Inc. (IDYA) on 27 Jun 2024.

Key facts

  • This page summarizes Jason Throne's Form 4 filing for IDEAYA Biosciences, Inc. (IDYA).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 27 Jun 2024, 18:47.

Change

  • Previous filing in this sequence was filed on 04 Mar 2024.
  • Current net transaction value: +$415,587.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IDYA transaction

Common Stock

Options Exercise

Transaction value
$85,696
Shares
+6,424
Change %
+64%
Price
$13.34
Shares after
16,424
Date
27 Jun 2024
Ownership
Direct
IDYA transaction

Common Stock

Options Exercise

Transaction value
$329,891
Shares
+47,060
Change %
+287%
Price
$7.01
Shares after
63,484
Date
27 Jun 2024
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IDYA transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-6,424
Change %
-13%
Price
$0.000000
Shares after
41,186
Date
27 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,424
Exercise price
$13.34
Footnotes
F1
IDYA transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-47,060
Change %
-97%
Price
$0.000000
Shares after
1,360
Date
27 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
47,060
Exercise price
$7.01
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

25% of the shares subject to the option vest on the first anniversary measured from July 1, 2020 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Footnote F2

The shares subject to the option are fully vested and exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .